Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$60.88 - $161.91 $13,758 - $36,591
-226 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$46.59 - $83.68 $14,815 - $26,610
-318 Reduced 58.46%
226 $15,000
Q4 2020

Jan 13, 2021

BUY
$18.83 - $63.53 $6,100 - $20,583
324 Added 147.27%
544 $30,000
Q3 2020

Nov 12, 2020

BUY
$17.47 - $24.93 $3,843 - $5,484
220 New
220 $4,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.19B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.